Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
1.027
+0.140 (15.85%)
Nov 21, 2024, 2:44 PM EST - Market open
Verrica Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 9.21 | 5.12 | 9.03 | 12 | - | - | Upgrade
|
| Revenue Growth (YoY) | 187.45% | -43.27% | -24.73% | - | - | - | Upgrade
|
| Cost of Revenue | 22.68 | 21.04 | 12.92 | 15.93 | - | - | Upgrade
|
| Gross Profit | -13.47 | -15.92 | -3.89 | -3.93 | - | - | Upgrade
|
| Selling, General & Admin | 65.14 | 47.31 | 17.41 | 26.98 | 24.51 | 14.64 | Upgrade
|
| Research & Development | -4.3 | - | - | - | 15.67 | 15.44 | Upgrade
|
| Operating Expenses | 60.84 | 47.31 | 17.41 | 26.98 | 40.18 | 30.08 | Upgrade
|
| Operating Income | -74.31 | -63.22 | -21.3 | -30.91 | -40.18 | -30.08 | Upgrade
|
| Interest Expense | -9.37 | -3.96 | -2.17 | -4.3 | -3.03 | - | Upgrade
|
| Interest & Investment Income | 2 | 2.74 | 0.48 | 0.12 | 0.52 | 1.88 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.02 | -0.01 | -0.06 | - | - | -0 | Upgrade
|
| EBT Excluding Unusual Items | -81.65 | -64.46 | -23.05 | -35.08 | -42.69 | -28.21 | Upgrade
|
| Gain (Loss) on Sale of Assets | -2.54 | -2.54 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | -1.44 | - | - | - | Upgrade
|
| Pretax Income | -84.99 | -67 | -24.49 | -35.08 | -42.69 | -28.21 | Upgrade
|
| Earnings From Continuing Operations | - | -67 | -24.49 | -35.08 | -42.69 | -28.21 | Upgrade
|
| Net Income | -84.99 | -67 | -24.49 | -35.08 | -42.69 | -28.21 | Upgrade
|
| Net Income to Common | -84.99 | -67 | -24.49 | -35.08 | -42.69 | -28.21 | Upgrade
|
| Shares Outstanding (Basic) | 47 | 45 | 34 | 27 | 25 | 25 | Upgrade
|
| Shares Outstanding (Diluted) | 47 | 45 | 34 | 27 | 25 | 25 | Upgrade
|
| Shares Change (YoY) | 5.62% | 32.72% | 26.32% | 8.20% | 0.39% | 69.80% | Upgrade
|
| EPS (Basic) | -1.83 | -1.48 | -0.72 | -1.30 | -1.71 | -1.13 | Upgrade
|
| EPS (Diluted) | -1.83 | -1.48 | -0.72 | -1.30 | -1.71 | -1.13 | Upgrade
|
| Free Cash Flow | -59.62 | -38.94 | -18.95 | -28.47 | -31.68 | -28.09 | Upgrade
|
| Free Cash Flow Per Share | -1.28 | -0.86 | -0.55 | -1.05 | -1.27 | -1.13 | Upgrade
|
| Gross Margin | -146.28% | - | -43.08% | -32.74% | - | - | Upgrade
|
| Operating Margin | -806.82% | -1233.84% | -235.78% | -257.57% | - | - | Upgrade
|
| Profit Margin | -922.81% | -1307.47% | -271.11% | -292.33% | - | - | Upgrade
|
| Free Cash Flow Margin | -647.38% | -759.93% | -209.83% | -237.21% | - | - | Upgrade
|
| EBITDA | -73.39 | -62.67 | -20.84 | -30.66 | -40.14 | -30.02 | Upgrade
|
| EBITDA Margin | - | - | -230.76% | -255.53% | - | - | Upgrade
|
| D&A For EBITDA | 0.92 | 0.55 | 0.45 | 0.24 | 0.04 | 0.06 | Upgrade
|
| EBIT | -74.31 | -63.22 | -21.3 | -30.91 | -40.18 | -30.08 | Upgrade
|
| EBIT Margin | - | - | -235.78% | -257.57% | - | - | Upgrade
|
| Revenue as Reported | 9.21 | 5.12 | 9.03 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.